Clinical Trials Directory

Trials / Completed

CompletedNCT02896777

Triple-arm pH Comparison

Triple-arm Trial of pH (Tri-pH) Effect on Live Birth After ICSI

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,273 (actual)
Sponsor
Ibn Sina Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The culturing human embryo in vitro is a process of myriad contributing elements. From these factors is the pH of embryo culture media, which is crucial for embryo development. The investigators plan to examine three different pH values of the culture media on the live birth rate of in vitro cultured human embryos.

Detailed description

In vitro fertilisation laboratory is the black box in which early human embryo development of infertile couple occurs. This laboratory holds many variables such as incubator type, air quality, brands of culture media, culture temperature and the pH of culture medium. Despite the importance of the culture medium pH, there is no single RCT has examined its effect on live birth rate post in vitro fertilisation. The investigators of this study believe that leaving this crucial element to the wishes of large companies and media designers is unwise. This RCT aims to provide a conclusive answer on pH effect on live birth rate of in vitro cultured human embryos.

Conditions

Interventions

TypeNameDescription
OTHERTransfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.20±0.02.
OTHERTransfer embryo from pH 7.3±0.02 either Day 3 or day 5/6Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.3±0.02.
OTHERTransfer embryo from pH of 7.4±0.02 on either Day 3 or day 5/6Post IVF/ICSI and according to the result of the randomization process, women will receive embryo from their oocytes that will be cultured in pH of 7.4±0.02 from day 0 to 5/6

Timeline

Start date
2020-06-13
Primary completion
2023-04-27
Completion
2023-08-11
First posted
2016-09-12
Last updated
2023-08-21

Locations

6 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02896777. Inclusion in this directory is not an endorsement.